why choose us

300×250 Ad Slot

Research Article: Transarterial Chemoembolization Plus Lenvatinib and PD- Inhibitors for Hepatocellular Carcinoma with Main Trunk Portal Vein Tumor Thrombus: A Multicenter Retrospective Study

Date Published: 2023-10-11

Introduction:
Hepatocellular carcinoma (HCC) is a major cause of cancer-associated mortality worldwide, with a poor prognosis. A dismal prognostic factor is portal vein tumor thrombus (PVTT), detected in approximately –% of HCC patients at diagnosis and portends a median survival rate of .–. months without treatment.

Read more

300×250 Ad Slot